Reaction

Pulmonary Pain reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,834 reports · 109 co-occurring drugs

As of the last recalculation, Pulmonary Pain appears in 2,834 FAERS reports alongside 109 co-occurring drug terms. The strongest observed disproportionality signal is THEOPHYLLINE (PRR 50.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Theophylline	77	50.5	50.9
Theophylline Anhydrous	78	47.5	47.8
Zinc	104	32.1	32.2
Zinc Chloride	104	31.9	32.0
Zinc Gluconate	105	30.6	30.7
Ketoprofen	42	23.9	23.9
Irbesartan	124	21.3	21.3
Cetiirizine	116	20.9	21.0
Amikacin	43	18.8	18.8
Elexacaftor, Tezacaftor, And Ivacaftor	26	15.4	15.5
Lanreotide Acetate	16	15.1	15.1
0Xygen	96	14.8	14.8
Oxygen	96	14.8	14.8
Nintedanib	61	14.6	14.6
Ezetimibe	132	13.5	13.5
Methocarbamol Tablets	30	13.3	13.3
Carbamazepine	116	13.2	13.2
Venlafaxine	123	13.1	13.2
Riociguat	57	13.1	13.1
Cetirizine	129	12.7	12.8
Ribociclib	53	12.5	12.6
Treprostinil	200	12.5	12.5
Selexipag	41	11.8	11.8
Tamsulosin Hydrochloride	32	11.6	11.7
Macitentan	104	11.4	11.4
Trimethoprim	18	11.3	11.3
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	59	10.7	10.7
Ciprofloxacin Hydrochloride	135	10.7	10.7
Budesonide, Glycopyrrolate, And Formoterol Fumarate	15	10.6	10.6
Ciprofolxacin	100	10.6	10.6
Ciprofloxacin Tablets	100	10.6	10.6
Diphenhydramine Hydrochloride Capsule, Liquid Filled	30	10.4	10.4
Fluticasone Furoate	17	10.4	10.4
Ciclesonide	19	10.3	10.3
Omalizumab	114	10.2	10.2
Methocarbamol	31	10.1	10.1
Mepolizumab	63	9.5	9.5
Fluticasone Propionate And Salmeterol Xinafoate	74	9.3	9.3
Tiotropium Bromide Inhalation Spray	14	9.2	9.2
Ciprofloxacin	108	8.9	9.0
Doxycycline Hyclate	78	8.7	8.7
Fluticasone Furoate And Vilanterol Trifenatate	42	8.7	8.7
Doxycycline	78	8.6	8.6
Pirfenidone	47	8.6	8.6
Mometasone Furoate And Formoterol Fumarate Dihydrate	17	8.0	8.1
Doxyclycline Hyclate	18	7.8	7.8
Lumacaftor And Ivacaftor	9	7.7	7.7
Venlafaxine Hydrochloride	131	7.6	7.6
Dornase Alfa	20	7.5	7.5
Loperamide Hydrochloride Oral	10	7.2	7.2
Albuterol Sulfate	266	7.2	7.2
Sildenafil	55	7.1	7.1
Umeclidinium Bromide And Vilanterol Trifenatate	16	7.1	7.1
Desoximetasone	18	7.0	7.0
Anastrozole Tablets	20	6.9	6.9
Amoxicillin	70	6.9	6.9
Cetirizine Hydrochloride	146	6.8	6.8
Budesonide And Formoterol Fumarate Dihydrate	86	6.7	6.7
Sildenafil Powder,	32	6.7	6.7
Ipratropium Bromide	32	6.7	6.7
Amitriptyline Hydrochloride	15	6.3	6.3
Montelukast Sodium	101	6.3	6.3
Epoprostenol	11	6.2	6.2
Tadalafil	81	6.1	6.1
Tiotropium Bromide	108	6.0	6.0
Montelukast	67	6.0	6.0
Benzonatate	13	5.8	5.8
Umeclidinium	7	5.8	5.8
Loperamide Hcl	10	5.7	5.7
Erlotinib	7	5.3	5.3
Infliximab-Dyyb	21	5.3	5.3
Fluticasone Propionate And Salmeterol	29	5.2	5.2
Omeprazole	226	5.1	5.1
Instalax Polyethylene Glycol 3350	8	4.7	4.7
Polyethylene Glycol 400	8	4.6	4.6
Sildenafil Citrate	76	4.5	4.5
Belimumab	19	4.4	4.4
Ambrisentan	73	4.4	4.4
Atorvastatin Calcium, Film Coated	40	4.2	4.2
Erlotinib Hydrochloride	7	4.1	4.1
Cabozantinib	26	4.0	4.0
Regorafenib	6	3.8	3.8
Bosentan	24	3.5	3.5
Ado-Trastuzumab Emtansine	4	3.5	3.5
Osimertinib	15	3.4	3.5
Benralizumab	9	3.3	3.3
Tobramycin	10	3.1	3.1
Acalabrutinib	5	3.0	3.0
Nirmatrelvir And Ritonavir	22	3.0	3.0
Fam-Trastuzumab Deruxtecan-Nxki	4	2.9	2.9
Ivacaftor	3	2.8	2.8
Clozapine	45	2.7	2.7
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	2.6	2.6
Sevelamer Carbonate	4	2.6	2.6
Durvalumab	7	2.5	2.5
Vismodegib	3	2.5	2.5
Siponimod	3	2.5	2.5
Pazopanib Hydrochloride	9	2.4	2.4
Crizotinib	4	2.3	2.3
Suvorexant	4	2.3	2.3
Etanercept	174	2.2	2.2
Remdesivir	4	2.2	2.2
Trifluridine And Tipiracil	3	2.1	2.1
Palbociclib	26	2.0	2.0
Relugolix	5	1.6	1.6
Dupilumab	71	1.1	1.1
Voxelotor	3	1.0	1.0
Galcanezumab-Gnlm	4	0.9	0.9
Evolocumab	19	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.